The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Only products for moderate/heavy incontinence, and only specific brands, were reimbursed by health insurances in 2019, thus limiting the selection. In addition, consumers with light incontinence, which is the majority of sufferers, did not get products via prescription, but had to purchase their own through retail outlets.
Many consumers who are embarrassed or misinformed regarding the issue of incontinence still failed to consult a doctor regarding the problem. Instead they ignored the issue or purchased products themselves, limiting the growth potential for Rx products.
Choice of brand or product selection was to a degree taken from the consumer, as only certain brands and product lines were reimbursed by insurance services. Apart from only moderate/heavy incontinence care products being eligible, brand availability was often restricted by region and/or insurance.
Sales of retail adult incontinence are now expected to grow by 3% in 2019 constant value terms in 2020 overall in light of the impact of COVID-19. This is in line with the 3% rise forecast in 2019 constant value terms in our 2020 edition of tissue and hygiene published in February 2020 (pre-COVID-19).
Economic recovery post COVID-19 is likely to stimulate demand for incontinence products. This is expected to occur as spending power increases, along with consumers’ propensity to travel.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Switzerland with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Switzerland market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.